Disease Area
Stroke Biomarker Research
Prevena Health is investigating molecular markers associated with cerebrovascular events. Our platform aims to support time-critical triage and clinical decision-making research through continuous biomarker surveillance.
Our Approach
Supporting stroke research with time-critical molecular data.
Stroke is one of the most time-sensitive medical emergencies. The window for effective clinical intervention is measured in hours, and the ability to rapidly characterize the type and severity of a cerebrovascular event may significantly influence outcomes. Yet current biomarker assessment typically occurs only after a patient reaches a clinical setting.
Prevena Health is exploring how continuous molecular surveillance might support earlier awareness of cerebrovascular biomarker changes. Our platform is being developed to track relevant analytes over time, potentially providing researchers and clinicians with longitudinal context that single-point emergency testing cannot offer.
This approach is particularly relevant for research into stroke triage, where the ability to differentiate between ischemic and hemorrhagic events using molecular data may support more informed clinical decision-making. Prevena aims to contribute a continuous data layer to complement existing imaging and clinical assessment tools.
Key Biomarkers
Molecular signals associated with cerebrovascular events.
GFAP (Glial Fibrillary Acidic Protein)
A structural protein of astrocytes associated with brain injury. GFAP elevation in blood is being investigated as a marker that may help differentiate hemorrhagic from ischemic stroke in research settings.
UCH-L1 (Ubiquitin C-Terminal Hydrolase L1)
A neuronal protein associated with brain cell injury. UCH-L1 is being explored alongside GFAP as part of multi-marker panels for cerebrovascular event characterization research.
D-dimer
A fibrin degradation product associated with coagulation activity. D-dimer trends may provide context for research into thromboembolic stroke mechanisms and recurrence risk assessment.
S100B
A calcium-binding protein released by glial cells, associated with blood-brain barrier disruption and brain tissue injury. S100B dynamics may support research into stroke severity and outcome prediction.
MMP-9 (Matrix Metalloproteinase-9)
An enzyme associated with extracellular matrix breakdown and blood-brain barrier permeability. MMP-9 is being investigated for its potential association with hemorrhagic transformation risk in stroke research.
Why It Matters
Why time-critical biomarker data matters for stroke.
Stroke is a leading cause of disability. Stroke remains one of the top causes of long-term disability and death globally. Outcomes are highly dependent on the speed and accuracy of initial clinical assessment and intervention.
Minutes matter in stroke triage. The distinction between ischemic and hemorrhagic stroke determines the course of treatment. Molecular biomarker data may support faster, more informed triage decisions in research and clinical settings.
Pre-hospital data is largely absent today. Most cerebrovascular biomarker data is obtained only after hospital arrival. Continuous surveillance may provide a pre-event baseline that contextualizes acute changes.
Recurrence risk requires ongoing monitoring. Patients who have experienced a cerebrovascular event face elevated risk of recurrence. Longitudinal molecular data may support research into post-stroke surveillance and secondary prevention strategies.
Prevena Health's platform is in development and is not commercially available. It has not been cleared, approved, or authorized by the U.S. Food and Drug Administration (FDA) or any other regulatory body. It is not a diagnostic device. Content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. This website and any future Prevena Health product or alerting function are not emergency services. Do not use them as a substitute for calling 911 or seeking immediate medical care.
Partner with us on stroke biomarker research.
We are seeking neurology researchers, stroke centers, and emergency medicine teams to explore continuous cerebrovascular biomarker surveillance.
Partner With Us